Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03041831 · ClinicalTrials.gov registry record

MOWI Qualitative Assessment

A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
40
Enrollment target

NCT03041831: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT03041831 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03041831 has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

This qualitative study seeks to assess whether mobile health technologies are helpful for older adults. It is the first in a series of four studies whose overarching goal is to conduct a program of pilot research aimed at developing and evaluating a technology-assisted wellness intervention for older adults with obesity who may or may not live in a rural area.

Primary Outcome

The investigators will record and transcribe each interview and focus group discussion for post-hoc evaluation. The investigators will then use the transcripts to identify themes on perceptions and experience with technology use in older adults.

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2016-08-15
Est. Completion 2020-04-28
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT03041831 record still lists

NCT03041831 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03041831 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03041831 about?

NCT03041831 is a clinical study titled "MOWI Qualitative Assessment". This qualitative study seeks to assess whether mobile health technologies are helpful for older adults. It is the first in a series of four studies whose overarching goal is to conduct a program of pilot research aimed at developing and evaluating a technology-assisted wellness intervention for olde...

What is the current status of trial NCT03041831?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-08-15. Estimated completion is 2020-04-28.

Who is sponsoring clinical trial NCT03041831?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03041831, the US trial registry maintained by the National Library of Medicine. NCT03041831 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.